Nasopharyngeal bacterial load as a marker for rapid and easy diagnosis of invasive pneumococcal disease in children from Mozambique

PLoS One. 2017 Sep 14;12(9):e0184762. doi: 10.1371/journal.pone.0184762. eCollection 2017.

Abstract

Background: Current diagnostic methods for detection of Streptococcus pneumoniae in children with suspected invasive pneumococcal disease have limitations of accuracy, timeliness, and patient convenience. This study aimed to determine the performance of pneumococcal load quantified with a real-time polymerase-chain reaction in nasopharyngeal samples to diagnose invasive pneumococcal disease in children.

Methods: Matched case-control study of patients <5 years of age with invasive pneumococcal disease admitted to the Manhiça District Hospital (Mozambique) and asymptomatic controls recruited in different periods between 2006 and 2014. Cases were confirmed by a positive bacterial culture for S. pneumoniae in blood or cerebrospinal fluid. Nasopharyngeal aspirates were collected from cases and controls and pneumococcal density was quantified by lytA real-time polymerase-chain reaction.

Results: Thirty cases (median age 12.8 months) and sixty controls (median age 11.7 months) were enrolled and 70% of them were male. Nasopharyngeal pneumococcal carriage was high in both groups: 28/30 (93.3%) for cases vs. 53/60 (88.3%) for controls (p = 0.71). Mean nasopharyngeal pneumococcal load was identified as a marker for invasive pneumococcal disease (7.0 log10 copies/mL in cases vs. 5.8 log10 copies/mL in controls, p<0.001) and showed good discriminatory power (AUC-ROC: 82.1%, 95% CI 72.5%-91.8%). A colonization density of 6.5 log10 copies/mL was determined as the optimal cut-off value to distinguish cases from controls (sensitivity 75.0%, specificity 73.6%).

Conclusion: Use of non-invasive nasopharyngeal aspirates coupled with rapid and accurate quantification of pneumococcal load by real-time polymerase chain reaction has the potential to become a useful surrogate marker for early diagnosis of invasive pneumococcal disease in children.

MeSH terms

  • Bacterial Load
  • Bacterial Proteins / genetics*
  • Case-Control Studies
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Male
  • Mozambique
  • Nasopharynx / microbiology*
  • Pneumococcal Infections / diagnosis*
  • Prospective Studies
  • Real-Time Polymerase Chain Reaction / methods*
  • Sensitivity and Specificity
  • Streptococcus pneumoniae / isolation & purification*
  • Streptococcus pneumoniae / physiology

Substances

  • Bacterial Proteins

Grants and funding

This work was supported by Fondo Europeo de Desarrollo Regional (FEDER) and the Ministry of Science and Innovation, Instituto de Salud Carlos III (ISCIII), Projects of Research on Health [FIS project number PI13/01729, Principal Investigator: Carmen Muñoz-Almagro]. Quique Bassat had during the time of the study a fellowship from the program Miguel Servet of the Instituto de Salud Carlos III [Plan Nacional de I+D+I 2008-2011, grant number: CP11/00269] (http://www.isciii.es/). The OVERLAP Project was supported by a grant from the World Health Organization [grant number: WHO-C6-181-489] (http://www.who.int/es/). The RAPID Project was supported by the Bill & Melinda Gates Foundation [grant number: OPP50092] (http://www.gatesfoundation.org/es/). The Centro de Investigação em Saúde de Manhiça – Fundaçao Manhiça (CISM – FM) receives financial support from the Spanish Agency for International Cooperation and Developement (AECID). ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.